Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
The Journal of Infection|June 26, 2013
Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional studyFrançoise Lunel-Fabiani, Wael Mansour, Abdellahi Ould Amar, et al.The Lancet. Gastroenterology & Hepatology|October 2, 2017
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trialMichel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.Viruses|August 29, 2024
The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide StudyIjeoma M Ifeorah, Athenais Gerber, Samira Dziri, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 24, 2017
Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed countryPierre O Sellier, Sarah Maylin, Ségolène Brichler, et al.Journal of Medical Virology|September 1, 2018
Hepatitis B virus and hepatitis delta virus subtypes circulating in Algeria and seroprevalence of HDV infectionSamir Gourari, Ségolène Brichler, Frédéric Le Gal, et al.The Journal of Antimicrobial Chemotherapy|May 31, 2023
HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretroviralsAlexandra Duhant, Byabene Kusinza, Claire Tantet, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 17, 2021
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-lifeTarik Asselah, Dimitri Loureiro, Fréderic Le Gal, et al.Hepatology (Baltimore, Md.)|August 28, 2023
HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R Battersby, et al.Journal of Hepatology|July 8, 2020
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis deltaDominique Roulot, Ségolène Brichler, Richard Layese, et al.Pageof 6